To Content

News

  • Patent granted in USA
    May 28,2010
    A composition patent protecting combinations of Biotec Pharmacon’s proprietary compound soluble yeast beta-glucan (SBG) as an adjuvant together with monoclonal antibodies for treatment of cancer has been granted in the U.S.
    More » 
  • Q1-2010 Presentation as WebCast
    April 29,2010
    Biotec Phamacon will present its report for Q1 2010 on May 11th at 09:00. The presentation will be held at Thon Conference Vika Atrium, Oslo. The presentation will also be available as webcast.
    More » 
  • Ordinary General Meeting
    April 13,2010
    The Board of Directors has today given notice of ordinary general meeting in Biotec Pharmacon to be held May 4th, 2010, at 15:00. The meeting will be held at the company's premises in Strandgata 3, Tromsø, Norway.
    More » 

Menu

CorePublish publiseringsverktøy